$CTIC Recent Headlines Insider filings one way t
Post# of 89347
Posted On: 11/17/2013 9:56:01 AM
$CTIC Recent Headlines
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com
BlackBerry Gets Downgraded, Vanda’s Meteoric Rise, and 3 More Hot Stocks 1:53 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Bank of America Disallows Online Gambling Transactions and 2 Other Hot Stocks to Watch 11:32 a.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Baxter, Cell Therapeutics Sign Licensing Agreement 9:18 a.m. Nov. 15, 2013 - WSJ.com
Will the New Arthritis Drug Help Celgene Surge Higher? 7:05 p.m. Nov. 9, 2013 - Wall St. Cheat Sheet
9 Biotechnology Stocks to Sell Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Deal Or No Deal: Hedge Funds Like These 6 Small Cap Stocks Under 5 Dollars 4:52 p.m. Nov. 5, 2013 - TheStreet.com
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, BP, Gap, Teva and More 7:41 a.m. Nov. 4, 2013 - 247WallSt.com
Cell Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript 11:50 p.m. Oct. 30, 2013 - Seeking Alpha
10-Q: CELL THERAPEUTICS INC 5:20 p.m. Oct. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics, Inc. Discusses Q3 2013 Results (Webcast) 4:25 p.m. Oct. 30, 2013 - Seeking Alpha
2 Speculative Biotechs For The 'Shotgun Investor' 11:12 a.m. Oct. 29, 2013 - Seeking Alpha
Will Celgene Continue to Trade at All-Time Highs? 6:19 p.m. Oct. 28, 2013 - Wall St. Cheat Sheet
Interesting CTIC Put And Call Options For June 2014 10:53 a.m. Oct. 23, 2013 - TheStreet.com
Cell Therapeutics Announces Results from Preclinical Study of Pixantrone at AACR-NCI-EORTC Conference 5:26 a.m. Oct. 21, 2013 - benzinga.com
Cell Therapeutics Must Deliver on Promise for Myelofibrosis Drug Partner 8:14 a.m. Oct. 8, 2013 - TheStreet.com
Zynga Founder Is Bored With Games and 2 More Heavily Traded Stocks to Follow 4:58 p.m. Oct. 7, 2013 - Wall St. Cheat Sheet
Cell Therapeutics Reaches Agreement with FDA on SPA for Planned Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis 4:56 a.m. Oct. 7, 2013 - benzinga.com
Cell Therapeutics: Sell Now, Ask Questions Later... Again 6:22 p.m. Sept. 29, 2013 - Seeking Alpha
First Week Of November 16th Options Trading For Cell Therapeutics (CTIC) 2:04 p.m. Sept. 26, 2013 - TheStreet.com
10 Biotechnology Stocks to Sell Now 5:45 a.m. Sept. 4, 2013 - InvestorPlace.com
CTIC, TTS, EGHT and ICLD to NASDAQ Active Stock Watch List at EPR 10:12 a.m. Nov. 15, 2013 - ACCESSWIRE
Cell Therapeutics to Host Conference Call Today, Friday, November 15, 2013, at 8:30 a.m. Eastern Time, to Discuss Pacritinib Partnership 7:36 a.m. Nov. 15, 2013 - PR Newswire
Baxter and Cell Therapeutics Announce Worldwide Strategic Collaboration to Develop and Commercialize Pacritinib 7:30 a.m. Nov. 15, 2013 - BusinessWire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
CTI Announces Data Presentations at the 55th American Society of Hematology Annual Meeting 4:00 p.m. Nov. 7, 2013 - PR Newswire
M&A, Earnings and News Round Up: Keryx Biopharmaceuticals, Pandora Media, Marvell Technology Group, Starbucks, Cell Therapeutics 8:46 a.m. Nov. 6, 2013 - PR Newswire
Cell Therapeutics Reports Third Quarter 2013 Financial Results 3:00 p.m. Oct. 30, 2013 - PR Newswire
Cell Therapeutics to Report Third Quarter Financial Results after Market on October 30, 2013 12:30 a.m. Oct. 23, 2013 - PR Newswire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 8:05 a.m. Oct. 21, 2013 - PR Newswire
Cell Therapeutics Announces Results from Preclinical Study of Pixantrone (PIXUVRI®) Presented at the AACR-NCI-EORTC Meeting 12:30 a.m. Oct. 21, 2013 - PR Newswire
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) 12:30 a.m. Oct. 15, 2013 - PR Newswire
Cell Therapeutics Adds Three Leaders in Blood Cancer Research and Development to Scientific Advisory Board 12:30 a.m. Oct. 14, 2013 - PR Newswire
Stock Option Grants, FDA Agreements, Financing Transactions, Clinical Trial Updates, and New Appointments - Research Report on Aegerion, CTI, PDL, Halozyme, and Acorda 7:00 a.m. Oct. 10, 2013 - PR Newswire
Cell Therapeutics Announces Agreement with the FDA on Special Protocol Assessment for Planned Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis 12:30 a.m. Oct. 7, 2013 - PR Newswire
Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc. 7:52 a.m. Sept. 25, 2013 - PR Newswire
Cell Therapeutics Announces Closing of Sale of Convertible Preferred Stock 12:30 a.m. Sept. 19, 2013 - PR Newswire
Cell Therapeutics Announces Sale of Convertible Preferred Stock 12:30 a.m. Sept. 13, 2013 - PR Newswire
Technical Study: ACADIA Pharma Inc., Medivation Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:21 a.m. Aug. 19, 2013 - PR Newswire
Market Access Granted in France for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) 12:30 a.m. Aug. 19, 2013 - PR Newswire
Cell Therapeutics Reports Second Quarter 2013 Financial Results 3:00 p.m. July 31, 2013 - PR Newswire
Insider filings one way to track tricky micro-cap biotechs 11:14 a.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 3:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 6:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 3:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 7:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 6:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 5:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 3:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 9:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 4:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 4:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 10:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 4:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 4:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 1:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 4:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 4:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 3:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 8:09 a.m. June 30, 2011 - MarketWatch.com
BlackBerry Gets Downgraded, Vanda’s Meteoric Rise, and 3 More Hot Stocks 1:53 p.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Bank of America Disallows Online Gambling Transactions and 2 Other Hot Stocks to Watch 11:32 a.m. Nov. 15, 2013 - Wall St. Cheat Sheet
Baxter, Cell Therapeutics Sign Licensing Agreement 9:18 a.m. Nov. 15, 2013 - WSJ.com
Will the New Arthritis Drug Help Celgene Surge Higher? 7:05 p.m. Nov. 9, 2013 - Wall St. Cheat Sheet
9 Biotechnology Stocks to Sell Now 5:15 a.m. Nov. 6, 2013 - InvestorPlace.com
Deal Or No Deal: Hedge Funds Like These 6 Small Cap Stocks Under 5 Dollars 4:52 p.m. Nov. 5, 2013 - TheStreet.com
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, BP, Gap, Teva and More 7:41 a.m. Nov. 4, 2013 - 247WallSt.com
Cell Therapeutics Management Discusses Q3 2013 Results - Earnings Call Transcript 11:50 p.m. Oct. 30, 2013 - Seeking Alpha
10-Q: CELL THERAPEUTICS INC 5:20 p.m. Oct. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics, Inc. Discusses Q3 2013 Results (Webcast) 4:25 p.m. Oct. 30, 2013 - Seeking Alpha
2 Speculative Biotechs For The 'Shotgun Investor' 11:12 a.m. Oct. 29, 2013 - Seeking Alpha
Will Celgene Continue to Trade at All-Time Highs? 6:19 p.m. Oct. 28, 2013 - Wall St. Cheat Sheet
Interesting CTIC Put And Call Options For June 2014 10:53 a.m. Oct. 23, 2013 - TheStreet.com
Cell Therapeutics Announces Results from Preclinical Study of Pixantrone at AACR-NCI-EORTC Conference 5:26 a.m. Oct. 21, 2013 - benzinga.com
Cell Therapeutics Must Deliver on Promise for Myelofibrosis Drug Partner 8:14 a.m. Oct. 8, 2013 - TheStreet.com
Zynga Founder Is Bored With Games and 2 More Heavily Traded Stocks to Follow 4:58 p.m. Oct. 7, 2013 - Wall St. Cheat Sheet
Cell Therapeutics Reaches Agreement with FDA on SPA for Planned Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis 4:56 a.m. Oct. 7, 2013 - benzinga.com
Cell Therapeutics: Sell Now, Ask Questions Later... Again 6:22 p.m. Sept. 29, 2013 - Seeking Alpha
First Week Of November 16th Options Trading For Cell Therapeutics (CTIC) 2:04 p.m. Sept. 26, 2013 - TheStreet.com
10 Biotechnology Stocks to Sell Now 5:45 a.m. Sept. 4, 2013 - InvestorPlace.com
CTIC, TTS, EGHT and ICLD to NASDAQ Active Stock Watch List at EPR 10:12 a.m. Nov. 15, 2013 - ACCESSWIRE
Cell Therapeutics to Host Conference Call Today, Friday, November 15, 2013, at 8:30 a.m. Eastern Time, to Discuss Pacritinib Partnership 7:36 a.m. Nov. 15, 2013 - PR Newswire
Baxter and Cell Therapeutics Announce Worldwide Strategic Collaboration to Develop and Commercialize Pacritinib 7:30 a.m. Nov. 15, 2013 - BusinessWire
Morning Research: Medivation Inc., ACADIA Pharma Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:00 a.m. Nov. 11, 2013 - PR Newswire
CTI Announces Data Presentations at the 55th American Society of Hematology Annual Meeting 4:00 p.m. Nov. 7, 2013 - PR Newswire
M&A, Earnings and News Round Up: Keryx Biopharmaceuticals, Pandora Media, Marvell Technology Group, Starbucks, Cell Therapeutics 8:46 a.m. Nov. 6, 2013 - PR Newswire
Cell Therapeutics Reports Third Quarter 2013 Financial Results 3:00 p.m. Oct. 30, 2013 - PR Newswire
Cell Therapeutics to Report Third Quarter Financial Results after Market on October 30, 2013 12:30 a.m. Oct. 23, 2013 - PR Newswire
Pre-Market Review: ACADIA Pharma Inc., Cell Therapeutics Inc., Sarepta Therapeutics Inc., and Medivation Inc. 8:05 a.m. Oct. 21, 2013 - PR Newswire
Cell Therapeutics Announces Results from Preclinical Study of Pixantrone (PIXUVRI®) Presented at the AACR-NCI-EORTC Meeting 12:30 a.m. Oct. 21, 2013 - PR Newswire
Second Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) 12:30 a.m. Oct. 15, 2013 - PR Newswire
Cell Therapeutics Adds Three Leaders in Blood Cancer Research and Development to Scientific Advisory Board 12:30 a.m. Oct. 14, 2013 - PR Newswire
Stock Option Grants, FDA Agreements, Financing Transactions, Clinical Trial Updates, and New Appointments - Research Report on Aegerion, CTI, PDL, Halozyme, and Acorda 7:00 a.m. Oct. 10, 2013 - PR Newswire
Cell Therapeutics Announces Agreement with the FDA on Special Protocol Assessment for Planned Pivotal Phase 3 Trial of Pacritinib in Myelofibrosis 12:30 a.m. Oct. 7, 2013 - PR Newswire
Technical Study: Cell Therapeutics Inc., ACADIA Pharmaceuticals Inc., Sarepta Therapeutics Inc., and Medivation Inc. 7:52 a.m. Sept. 25, 2013 - PR Newswire
Cell Therapeutics Announces Closing of Sale of Convertible Preferred Stock 12:30 a.m. Sept. 19, 2013 - PR Newswire
Cell Therapeutics Announces Sale of Convertible Preferred Stock 12:30 a.m. Sept. 13, 2013 - PR Newswire
Technical Study: ACADIA Pharma Inc., Medivation Inc., Sarepta Therapeutics Inc., and Cell Therapeutics Inc. 8:21 a.m. Aug. 19, 2013 - PR Newswire
Market Access Granted in France for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI® (pixantrone) 12:30 a.m. Aug. 19, 2013 - PR Newswire
Cell Therapeutics Reports Second Quarter 2013 Financial Results 3:00 p.m. July 31, 2013 - PR Newswire
(0)
(0)